Return to Article Details TREATMENT RESULTS OF ADVANCED NON SMALL-CELL LUNG CANCER HARBOURING UNCOMMON EGFR MUTATIONS BY FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS Download Download PDF